The effects of vildagliptin compared with metformin on vascular endothelial function and metabolic parameters: a randomized, controlled trial (Sapporo Athero-Incretin Study 3)

DOI: 10.1186/s12933-017-0607-6

Keywords: Type 2 diabetes, Dipeptidyl peptidase-4 inhibitor, Vildagliptin, Vascular endothelial function

Full-Text   Cite this paper   Add to My Lib

Abstract:

The online version of this article (doi:10.1186/s12933-017-0607-6) contains supplementary material, which is available to authorized users

Full-Text